About Index Trending news
Analyze
Top 50 Pricing
Armune BioScience

Armune BioScience

Work at Armune BioScience? Add yourself to this profile

Armune BioScience

Developed the technology APIFINY®—a prostate-cancer-specific non-PSA blood test that may improve decision making when selecting men for prostate biopsies.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series A)
$5,000,000
Grand Angels Venture Fund II
Venture capital (Series A)
$9,710,000
Employees

Team size

10+
Locations
HQ
Headquarters
$5,000,000 Venture capital (Series A)
FinSMEs

Armune BioScience Closes $5M Series A Funding

Health Funding
$9,710,000 Venture capital (Series A)
grbj , Armune BioScience , sec

Medical diagnostics startup secures $9M in funding

Health Funding